Viewing Study NCT02298595


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2026-01-03 @ 9:31 PM
Study NCT ID: NCT02298595
Status: WITHDRAWN
Last Update Posted: 2017-11-13
First Post: 2014-11-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Sponsor: Julie E. Bauman, MD, MPH
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 14-057
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View